A partnership born in 2002, Niche has supported Cardionetics across medical writing, regulatory strategy and product value assessment for...
Niche crafted a strategic communications plan for ApaTech's synthetic bone graft portfolio, translating preclinical science into compelling manuscripts, regulatory documents and conference publications ahead of its $330 million acquisition.










